Indian shares set to open little changed
BENGALURU, Aug 28 (Reuters) -Indian shares, which are a whisker away from record highs, are set to open little changed on Wednesday, with traders expecting further profit booking ahead of key macroeconomic data later this week.
The GIFT Nifty GIFc1 was trading at 25,002.5 as of 08:07 a.m. IST, indicating that the NSE Nifty 50 .NSEI will open near its previous close of 25,017.75.
The Nifty 50, which has added about 3.6% in nine sessions, its longest daily winning run in 16 months, came within five points of a record high on Tuesday, helped by surplus liquidity.
Foreign institutional investors (FII) remained net buyers of Indian shares for a fourth session in a row on Tuesday, purchasing shares worth 15.04 billion rupees ($179.2 million) on a net basis.
Domestic institutional investors (DII) were also buyers of Indian stocks for 15 sessions until Monday.
Profit taking in overheated segments of the markets will likely continue further, two traders said, adding that caution has set innear record high levels, ahead of domestic growth data and U.S. inflation readings, due later in the week.
Asian markets opened lower on the day, with the MSCI Asia ex-Japan index .MIAPJ0000PUS shedding 0.4%. Wall Street equities closed marginally higher overnight ahead of a much-anticipated quarterly report from Nvidia NVDA.O and U.S. economic data.[MKTS/GLOB]
STOCKS TO WATCH
** ICICI Prudential Life ICIR.NS gets tax order for demand of 4.29 billion rupees.
** PNC Infratech PNCI.NS declared as lowest bidder by NHAI for a projected worth 3.8 billion rupees.
** Zydus Lifesciences ZYDU.NS receives US drug regulator's approval for drug used for treatment of Parkison's disease.
($1 = 83.9350 Indian rupees)
Reporting by Bharath Rajeswaran in Bengaluru; Editing by Sonia Cheema
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
